Cover Image
Market Research Report
Product code 
934339

Genital Warts (GWs) - Epidemiology Forecast to 2030

Published: Pre-Order | DelveInsight Business Research LLP | 102 Pages | Delivery time: 2-10 business days

Price

Back to Top
Genital Warts (GWs) - Epidemiology Forecast to 2030
Published: Pre-Order
DelveInsight Business Research LLP
Content info: 102 Pages
Delivery time: 2-10 business days
  • ALL
  • Description
  • Table of Contents
Description

DelveInsight's 'Genital Warts (GWs)- Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Genital Warts in the United States.

Geography Covered:

  • The United States

Study Period: 2017-2030

Genital Warts Disease Understanding

Genital warts (GWs) are transmitted by having sexual contact with someone who already has them, and may be found on the outside of genitals. Some types, which cause cancer, result in the growth of lesions on a woman's cervix. It is possible to get genital warts, HPV infection, even if they are not visible. They look like flesh-colored bumps that have a cauliflower-like appearance, and are usually flat, papular, or pedunculated growths on the genital mucosa, occurring in clusters. They can appear on the penis, vulva, vagina, cervix, groin, or thigh within weeks or months after sexual contact with an infected person. Potentially cancer-causing HPV strains are spread by sexual intercourse, anal sex, and oral sex. Moreover, genital Warts is also known as anogenital warts (AGWs) or condylomata acuminata.

Genital Warts Epidemiology

The Genital Warts (GWs) epidemiology division provides the insights about historical and current patient pool and forecasted trend the United States. The epidemiology data for Genital Warts are studied through all possible division to give a better understanding about the Disease scenario in the United States. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Genital Warts Epidemiology Segmentation

The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (Total Diagnosed Incidence of GWs, Gender-specific Cases, Age-specific Cases of Genital Warts, HPV type associated with GWs and Anatomical Location of Warts) in the United States from 2017-2030.

The DelveInsight report also provides the epidemiology trends observed in the US during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

According to DelveInsight, the total number of diagnosed incident cases of Genital Warts (GWs) in the US was found to be 4,65,000, in the year 2017.

Report Scope:

  • The report covers detailed overview of Genital Warts explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The report provides the insight about the historical and forecasted patient pool of Genital Warts in the United States
  • The Report assesses the disease risk and burden and highlights the unmet needs of the disease
  • The Report helps to recognize the growth opportunities in the United States with respect to the patient population
  • The report provides the segmentation of the disease epidemiology by Total Diagnosed Incidence of GWs, Gender-specific Cases, Age-specific Cases of Genital Warts, HPV type associated with GWs and Anatomical Location of Warts in the US

Key strengths

  • 11 Year Forecast of Genital Warts epidemiology
  • The US Coverage
  • Total incident cases of GWs
  • Incident Cases according to segmentation: Total Diagnosed Incidence of GWs, Gender-specific Cases, Age-specific Cases of Genital Warts, HPV type associated with GWs and Anatomical Location of Warts

Key assessments

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population
Table of Contents
Product Code: DIEI0964

Table of Contents

1 Key Insights

2 Executive Summary of GWs

3 SWOT Analysis for GWs

4 Disease Background and Overview

  • 4.1. Introduction
  • 4.2. Natural History
  • 4.3. Causes and Risks
  • 4.4. Symptoms
  • 4.5. Pathophysiology
  • 4.6. Clinical Presentation
  • 4.7. Complications of Untreated HVP Infection
  • 4.8. Diagnosis

5 Treatment and Management

6 Vaccines

  • 6.1. Gardasil: Merck
  • 6.2. Cervarix: GlaxoSmithKline
  • 6.3. Comparison
  • 6.4. Differences

7 Epidemiology and Patient Population

  • 7.1. Key Findings
  • 7.2. Country Wise-Epidemiology
  • 7.3. United States
    • 7.3.1. Assumptions and Rationale
    • 7.3.2. Diagnosed incidence of GWs in the United States
    • 7.3.3. Gender Specific Diagnosed Cases of GWs in the United States
    • 7.3.4. Age Specific Diagnosed Cases of GWs in the United States
    • 7.3.5. Anatomical Location of Genital Warts in the United States

8 Unmet Needs

9 Organizations related to GWs

10 Case Studies

  • 10.1. A Case Report of Genital Warts
  • 10.2. A Case Report of Condyloma Acuminata

11 Appendix

  • 11.1. References
  • 11.2. Report Methodology

12 DelveInsight Capabilities

13 Disclaimer

14 About DelveInsight

List of Tables

  • Table 1: Summary of Genital Warts (GWs) Market, Epidemiology, and Key Events (2017-2030)
  • Table 2: Low-risk HPV versus High-risk HPV
  • Table 3: Treatment Modalities
  • Table 4: Treatments and their Advantages
  • Table 5: Enhancing the efficacy of imiquimod
  • Table 6: Gardasil versus Cervarix
  • Table 7: Diagnosed Incident Population of GWs in the United States (2017-2030)
  • Table 8: Gender Specific Diagnosed Cases of GWs in the United States (2017-2030)
  • Table 9: Age Specific Diagnosed Cases of GWs in the United States (2017-2030)
  • Table 10: Anatomical Location of GWs in the United States (2017-2030)
  • Table 11: Organizations contributing toward Genital Warts

List of Figures

  • Figure 1: SWOT Analysis
  • Figure 2: Different Types of Warts
  • Figure 3: HPV Structure and Function
  • Figure 4: HPV Structure and Function
  • Figure 5: Infection by HPV
  • Figure 6: Checklist for Initial Consultation
  • Figure 7: Checklist for providing Treatment
  • Figure 8: Treatment Algorithm
  • Figure 9: Newer Simplified Treatment Algorithm
  • Figure 10: Algorithm for Treatment Selection
  • Figure 11: Algorithm for Treatment Selection in Pregnant Patients
  • Figure 12: Diagnosed Incidence of GWs in the United States (2017-2030)
  • Figure 13: Gender Specific Diagnosed Cases of GWs in the United States (2017-2030)
  • Figure 14: Age Specific Diagnosed Cases of GWs in the United States (2017-2030)
  • Figure 15: Anatomical Location of GWs in the United States (2017-2030)
  • Figure 16: Unmet needs for GWs